Related Experiment Videos

Trimethoprim and sulphamethoxazole in typhoid fever in children

British Medical Journal
|September 25, 1971
PubMed

Insights

Trimethoprim-sulfamethoxazole showed poor results for treating typhoid fever in children. Chloramphenicol remains the preferred treatment, though monitoring for blood changes is advised with trimethoprim-sulfamethoxazole.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Typhoid fever remains a significant global health concern, particularly in children.
  • Antibiotic resistance necessitates ongoing evaluation of effective treatment options.
  • Chloramphenicol has been a traditional treatment, but concerns about side effects exist.

Purpose of the Study:

  • To compare the efficacy and safety of trimethoprim-sulfamethoxazole versus chloramphenicol in treating childhood typhoid fever.
  • To assess the bacteriological response and identify potential adverse effects of trimethoprim-sulfamethoxazole.

Main Methods:

  • A comparative study involving 103 children treated with trimethoprim-sulfamethoxazole and 40 children treated with chloramphenicol.
  • Proved typhoid fever cases were included.
  • Bacteriological response and haematological changes were monitored.

Main Results:

  • Trimethoprim-sulfamethoxazole demonstrated an unsatisfactory bacteriological response in children with typhoid fever.
  • Chloramphenicol treatment yielded better outcomes.
  • Haematological changes were observed during trimethoprim-sulfamethoxazole therapy, necessitating monitoring.

Conclusions:

  • Chloramphenicol is currently the treatment of choice for typhoid fever.
  • Caution and blood picture monitoring are recommended when using trimethoprim-sulfamethoxazole due to potential haematological side effects.

Related Concept Videos